EAM
CRBU icon

Erste Asset Management’s Caribou Biosciences CRBU Stock Holding History

Erste Asset Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,900
Closed -$27.5K – 545
2024
Q3 		$27.5K Hold
13,900
– – ﹤0.01% 523
2024
Q2 		$23.4K Hold
13,900
– – ﹤0.01% 522
2024
Q1 		$71.2K Hold
13,900
– – ﹤0.01% 500
2023
Q4 		$81.7K Hold
13,900
– – ﹤0.01% 506
2023
Q3 		$65.7K Hold
13,900
– – ﹤0.01% 505
2023
Q2 		$56.7K Hold
13,900
– – ﹤0.01% 531
2023
Q1 		$71.4K Hold
13,900
– – ﹤0.01% 538
2022
Q4 		$84.1K Hold
13,900
– – ﹤0.01% 532
2022
Q3 		$145K Hold
13,900
– – ﹤0.01% 511
2022
Q2 		$77.3K Hold
13,900
– – ﹤0.01% 541
2022
Q1 		$129K Buy
+13,900
New +$146K ﹤0.01% 516

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
EWM
Elmwood Wealth Management Berkeley, California $400M AUM 17.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Erste Asset Management's CRBU Position: Q4 2024 in Review

Erste Asset Management sold out of Caribou Biosciences (CRBU) in Q4 2024, closing a stake of 13,900 shares — an estimated $27.5K sold.

Erste Asset Management first reported a position in CRBU in Q1 2022 and held it in 11 quarters. The position peaked at $145K in Q3 2022. 133 funds tracked by Wall St. Rank hold CRBU as of Q4 2024.

  • Erste Asset Management reported no remaining Caribou Biosciences position as of Q4 2024 after selling out during the quarter.
  • Erste Asset Management sold 13,900 Caribou Biosciences shares in Q4 2024, an estimated $27.5K.
  • Erste Asset Management first reported a position in Caribou Biosciences in Q1 2022 and held it in 11 quarters.
  • Erste Asset Management's Caribou Biosciences position peaked at $145K in Q3 2022.
  • 133 funds tracked by Wall St. Rank held Caribou Biosciences as of Q4 2024.

Based on Erste Asset Management's 13F filing for Q4 2024, filed 10 Feb 2025.